Maria Moriondo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 4

Top Topics

Escherichia Coli

Respiratory Syncytial Virus

Top Venues

Journal of chemotherapy (Florence, Italy)

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chiara Azzari, Maria Moriondo, Francesco Nieddu, Valentina Guarnieri, Lorenzo Lodi, Clementina Canessa, Giuseppe Indolfi, Mattia Giovannini, Giuseppina Napoletano, Francesca Russo, Tatjana Baldovin, Silvia Cocchio, Silvia Ricci, Vincenzo Baldo
Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014-2018). Vaccines 8 (3) (2020)
Lorenzo Lodi, Chiara Rubino, Silvia Ricci, Giuseppe Indolfi, Mattia Giovannini, Guglielmo Consales, Simone Magazzini, Franco Lai, Pierluigi Vasarri, Antonella Conti, Tamara Brunelli, Maria Moriondo, Chiara Azzari
Neisseria meningitidis with H552Y substitution on rpoB gene shows attenuated behavior in vivo: report of a rifampicin-resistant case following chemoprophylaxis. Journal of chemotherapy (Florence, Italy) 32 (2) (2020)
Federica Barbati, Maria Moriondo, Laura Pisano, Elisa Calistri, Lorenzo Lodi, Silvia Ricci, Mattia Giovannini, Clementina Canessa, Giuseppe Indolfi, Chiara Azzari
Epidemiology of Respiratory Syncytial Virus-Related Hospitalization Over a 5-Year Period in Italy: Evaluation of Seasonality and Age Distribution Before Vaccine Introduction. Vaccines 8 (1) (2020)
Marzia Monica Giuliani, Alessia Biolchi, Pavitra Keshavan, Maria Moriondo, Sara Tomei, Laura Santini, Elena Mori, Alessandro Brozzi, Margherita Bodini, Francesco Nieddu, Silvia Ricci, Thembile Mzolo, Marco Costantini, Chiara Azzari, Michele Pellegrini
Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children. Human vaccines & immunotherapeutics 17 (5) (2020)